119 related articles for article (PubMed ID: 3433577)
1. Enhanced expression of Harvey-ras oncogene in FANFT-induced transitional cell carcinoma.
Sawczuk IS; Walsh W; King W; Olsson CA; Nguyen-Huu C
Urol Int; 1987; 42(5):321-5. PubMed ID: 3433577
[TBL] [Abstract][Full Text] [Related]
2. Sequencing analysis of Ha-, Ki-, and N-ras genes in rat urinary bladder tumors induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) and sodium saccharin.
Masui T; Mann AM; Borgeson CD; Garland EM; Okamura T; Fujii H; Pelling JC; Cohen SM
Teratog Carcinog Mutagen; 1993; 13(5):225-33. PubMed ID: 7905676
[TBL] [Abstract][Full Text] [Related]
3. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model.
Steinberg GD; Brendler CB; Ichikawa T; Squire RA; Isaacs JT
Cancer Res; 1990 Oct; 50(20):6668-74. PubMed ID: 2208131
[TBL] [Abstract][Full Text] [Related]
5. Activating missense mutations in Ha-ras-1 genes in a malignant subset of bladder lesions induced by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-[4-(5-nitro-2-furanyl)-2-thiazolyl]formamide.
Jones RF; Debiec-Rychter M; Zukowski K; Wang CY
Mol Carcinog; 1990; 3(6):393-402. PubMed ID: 2278634
[TBL] [Abstract][Full Text] [Related]
6. Direct DNA sequencing of the rat neu oncogene transmembrane domain reveals no mutation in urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-methyl-N-nitrosourea.
Masui T; Mann AM; Macatee TL; Garland EM; Okamura T; Smith RA; Cohen SM
Carcinogenesis; 1991 Oct; 12(10):1975-8. PubMed ID: 1682063
[TBL] [Abstract][Full Text] [Related]
7. Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo.
Mann AM; Asamoto M; Chlapowski FJ; Masui T; Macatee TL; Cohen SM
Carcinogenesis; 1992 Sep; 13(9):1651-5. PubMed ID: 1394851
[TBL] [Abstract][Full Text] [Related]
8. Point mutation in codons 12 and 61 of the Ha-ras gene in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Masui T; Mann AM; Garland EM; Okamura T; Johansson PL; Cohen SM
Mol Carcinog; 1990; 3(4):210-5. PubMed ID: 2206284
[TBL] [Abstract][Full Text] [Related]
9. Neu is not involved in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide- induced bladder carcinoma or 2-amino-4-(5-nitro-2-furyl)thiazole transformation of rat bladder epithelial cells.
Mann AM; Asamoto M; Masui T; Macatee T; Eklund SH; Cohen SM
Cancer Lett; 1994 Aug; 84(1):7-13. PubMed ID: 7915640
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
Soloway MS; Martino C; Hyatt C; Marrone JC
Natl Cancer Inst Monogr; 1978 Dec; (49):293-300. PubMed ID: 748783
[TBL] [Abstract][Full Text] [Related]
11. Metastatic characteristics of four FANFT-induced murine bladder tumors.
Crabtree WN; Soloway MS; Matheny RB; Murphy WM
Urology; 1983 Nov; 22(5):529-31. PubMed ID: 6649210
[TBL] [Abstract][Full Text] [Related]
12. Enhancement by phenothiazine and 2,5-di-O-acetyl-D-glucosaccharo-(1,4)(6,3)-dilactone of bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in rats.
Wang CY; Hayashida S
Cancer Lett; 1984 Aug; 24(1):37-43. PubMed ID: 6548659
[TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of four N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) induced mouse bladder tumors.
Mickey DD; Mickey GH; Murphy WM; Niell HB; Soloway MS
J Urol; 1982 Jun; 127(6):1233-7. PubMed ID: 7087044
[TBL] [Abstract][Full Text] [Related]
14. Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats.
Imaida K; Wang CY
Cancer Res; 1986 Dec; 46(12 Pt 1):6160-4. PubMed ID: 3779637
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
16. Enhanced immunoreactivity of ras oncogene p21 protein in urinary bladder epithelium of rats treated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Masui T; Ward JM; Cohen SM
Cancer Lett; 1991 Aug; 59(2):95-102. PubMed ID: 1884376
[TBL] [Abstract][Full Text] [Related]
17. Protection from carcinogen-induced murine bladder carcinoma by interferons and an oral interferon-inducing pyrimidinone, bropirimine.
Borden EC; Sidky YA; Ertürk E; Wierenga W; Bryan GT
Cancer Res; 1990 Feb; 50(4):1071-4. PubMed ID: 2297754
[TBL] [Abstract][Full Text] [Related]
18. Cell line specific abnormalities in expression of PNA, SBA and L-PHA binding sites by carcinogen induced rat urothelial carcinomas.
Rak JW; Debiec-Rychter M; Miller FR; Wang CY
Neoplasma; 1992; 39(3):141-6. PubMed ID: 1528317
[TBL] [Abstract][Full Text] [Related]
19. Rat bladder isograft model for focal carcinoma.
Mei H; Hagen IK; Allhoff EP; Lin JC; Chapman CM; Proppe KH; Prout GR; Lin CW
J Urol; 1982 Sep; 128(3):629-32. PubMed ID: 7120581
[TBL] [Abstract][Full Text] [Related]
20. Activation of H-ras oncogene in rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Fujita J; Ohuchi N; Ito N; Reynolds SH; Yoshida O; Nakayama H; Kitamura Y
J Natl Cancer Inst; 1988 Mar; 80(1):37-43. PubMed ID: 3276902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
